Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 10, 2023

SELL
$8.72 - $11.56 $1,290 - $1,710
-148 Reduced 90.24%
16 $1,000
Q3 2022

Oct 24, 2022

SELL
$8.48 - $11.13 $347 - $456
-41 Reduced 20.0%
164 $1,000
Q2 2022

Jul 08, 2022

SELL
$9.95 - $12.27 $109 - $134
-11 Reduced 5.09%
205 $2,000
Q1 2022

Apr 20, 2022

BUY
$9.81 - $15.4 $2,118 - $3,326
216 New
216 $2,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15.2B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Bank Of New Hampshire Portfolio

Follow Bank Of New Hampshire and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New Hampshire, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New Hampshire with notifications on news.